Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$59.29 – $74.00
42% from low
Exchange
OTC Link
OS
BASILEA PHARM AG AKT SHS
No one on the platform currently holds BPMUF.
No tracked institution reports a position in BPMUF as of their last filing.
No one on the platform has traded BPMUF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $252M | +13.5% | $4.46 | $4.25–$4.72 | 14.7× | 1 |
| 2027 | $257M | +2.0% | $3.21 | $3.06–$3.40 | 20.4× | 1 |
| 2028 | $227M | -11.9% | $0.76 | $0.73–$0.81 | 85.9× | 1 |
| 2029 | $198M | -12.9% | $3.35 | $3.19–$3.54 | 19.6× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-02-17 | $2.06 | $1.95 | -5.3% |
| 2025-08-19 | $2.56 | $1.44 | -43.8% |
| 2025-02-18 | $3.57 | $4.52 | +26.6% |
| 2024-08-13 | $1.30 | $1.67 | +28.5% |
| 2024-04-24 | $-2.38 | $-2.08 | +12.5% |
| 2023-06-30 | $0.90 | $2.58 | +187.0% |
| 2022-12-31 | $-1.41 | $2.20 | +256.5% |
| 2022-06-30 | $-1.62 |
| $-1.08 |
| +33.6% |
| +0.00% |
| $461M |
| — |
| MDCLFMedinCell S.A. | $34.39 | +0.00% | $1.2B | — |
| PTCHFPureTech Health plc | $1.56 | +0.00% | $381M | — |
Source: Financial Modeling Prep · peers by sector/industry